Researchers from the Guerbet Group and the University of Münster in Germany recently found that 75 percent of the total gadolinium found in the cerebellum of rats after the injection period of the linear contrast agent gadodiamide was still retained after one year.

A group of German researchers found diffusion-weighted (DW) MRI provided superior prognostic information compared to PET/CT in liver cancer patients who underwent 90Y radioembolization and proved more accurate in predicting overall survival in these patients.

Officially sworn in this past October as the Director of the National Cancer Institute (NCI), Ned Sharpless, MD, believes that artificial intelligence will probably be in the future of cancer care.

Health insurance giant Anthem implemented its controversial imaging policy in Colorado last fall which has limited CT and MRI coverage for the nearly one in five patients with private insurance in the state, according to a Denver Post report. Some experts question the motivation of the move.

Detroit attorney Mike Morse has been accused by State Farm Insurance of having an undisclosed financial relationship with Horizon Imaging, a Michigan-based MRI provider that accepted referrals from Morse's law firm.

Geraldine McGinty, MD, MBA, has been elected Chair of the American College of Radiology (ACR) board—the first woman named to the position in the history of the organization.

Researchers from Drexel University and experts in aerospace engineering at ISAE-SUPAERO in Toulouse, France, found aircraft pilots commit more errors operating a real aircraft than a flight simulator by measuring brain activity using a portable, cognitive imaging system.

The development of acute kidney injury (AKI) has been linked to the use of contrast media during imaging, but a recent JACR study found these incidents have likely been overestimated.

Using functional MRI (fMRI), researchers from VU University Medical Center in Amsterdam found a correlation between white matter brain damage and atrophy in multiple sclerosis (MS) patients—a primary factor of cognitive impairment in patients with the disease.

Theresa May, Prime Minister of the United Kingdom, has pledged millions toward government funding that will develop a "new weapon"—artificial intelligence (AI) able to improve cancer and chronic disease diagnosis.